Sharp Shalini

Average Profitability
24.13%
Insider Buys Quantity
3
Insider Buys Sum
$133,744.00
Insider Sells Quantity
44
Insider Sells Sum
$18.8M

Insider Activity of Sharp Shalini

According to the SEC Form 4 filings, Sharp Shalini, being in a position of

  1. director at Neurocrine Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1106 shares for $156,943,
    over all time since 2024-05-17, has bought 0 shares, and sold 1106 shares for $156,943.

The largest purchase of all time was on 2014-01-30 and amounted to 4500 shares of Ultragenyx Pharmaceutical Inc. for $94,500.

The largest sale of all time was on 2018-05-30 and amounted to 26000 shares of Ultragenyx Pharmaceutical Inc. for $1.82M.

Biography of Sharp Shalini

No biography is available at this moment.

2024-05-17SaleNeurocrine Biosciences, Inc.
NBIX
director
1,106
0.0011%
$141.90$156,943-10.11%
2020-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
EVP, Finance
375
0.0006%
$87.99$32,996+15.06%
2020-08-17SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
6,690
0.0111%
$88.43$591,607+21.8%
2020-06-04SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
5,128
0.009%
$74.01$379,523+52.58%
2020-06-03SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
20,468
0.0289%
$61.33$1.26M+47.1%
2020-05-19SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
7,128
0.0122%
$73.32$522,625+48.76%
2020-05-18SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
21,985
0.037%
$73.33$1.61M+46.65%
2019-03-18SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
14,800
0.0285%
$70.00$1.04M-16.81%
2019-03-05SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
1,012
0.0019%
$65.52$66,306-13.14%
2018-09-25SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
6,700
0.0133%
$90.07$603,469-34.98%
2018-06-07SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
13,400
0.0268%
$80.07$1.07M-18.08%
2018-05-30SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
26,000
0.0506%
$70.17$1.82M-8.67%
2017-03-02SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
12,000
0.0302%
$90.10$1.08M-34.39%
2017-02-27SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
12,000
0.027%
$80.14$961,680-33.75%
2016-11-09SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Executive Vice President
24,000
0.0584%
$71.20$1.71M-11.06%
2016-10-19SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Senior Vice President
12,000
0.0294%
$61.40$736,820+4.15%
2015-12-10SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Senior Vice President
12,000
0.0311%
$101.66$1.22M-34.63%
2015-07-20SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Senior Vice President
7,708
0.0198%
$131.95$1.02M-42.71%
2015-06-18SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Senior Vice President
4,000
0.0109%
$96.08$384,340-4.68%
2015-05-18SaleUltragenyx Pharmaceutical Inc.
RARE
CFO & Senior Vice President
4,000
0.0109%
$79.43$317,720+15.37%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.